Phytoestrogens for Cancer Prevention and Treatment

Total Page:16

File Type:pdf, Size:1020Kb

Phytoestrogens for Cancer Prevention and Treatment biology Review Phytoestrogens for Cancer Prevention and Treatment Margalida Torrens-Mas 1,2 and Pilar Roca 1,2,3,* 1 Grupo Multidisciplinar de Oncología Traslacional, Institut Universitari d’Investigació en Ciències de la Salut, Universitat de les Illes Balears, 07122 Palma, Spain; [email protected] 2 Instituto de Investigación Sanitaria Illes Balears, 07010 Palma, Spain 3 Ciber Fisiopatología Obesidad y Nutrición (CB06/03), Instituto Salud Carlos III, 28029 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-971-17184 Received: 30 October 2020; Accepted: 25 November 2020; Published: 27 November 2020 Simple Summary: Phytoestrogens are compounds derived from plants that have a similar structure to human sex hormones. This has led to the observation that phytoestrogens have comparable effects to these hormones in our cells. Some beneficial effects of phytoestrogens include the improvement of menopausal symptoms and the prevention of several diseases. In fact, the consumption of soy and soy foods among the Asian population has been associated with a decrease in the incidence of some types of tumors. However, there are some concerns about whether these compounds may also have harmful effects, such as interfere with cancer treatments. In this review, we collect data on the reported effects of phytoestrogens alone or in combination with anti-cancer treatments and discuss the controversy around using these compounds. Abstract: Phytoestrogens are a large group of natural compounds found in more than 300 plants. They have a close structural similarity to estrogens, which allow them to bind to both estrogen receptors (ER), ERα and ERβ, presenting a weak estrogenic activity. Phytoestrogens have been described as antioxidant, anti-inflammatory, anti-thrombotic, anti-allergic, and anti-tumoral agents. Their role in cancer prevention has been well documented, although their impact on treatment efficiency is controversial. Several reports suggest that phytoestrogens may interfere with the effect of anti-cancer drugs through the regulation of oxidative stress and other mechanisms. Furthermore, some phytoestrogens could exert a protective effect on healthy cells, thus reducing the secondary effects of cancer treatment. In this review, we have studied the recent research in this area to find evidence for the role of phytoestrogens in cancer prevention and therapy efficacy. Keywords: phytoestrogens; cancer prevention; cancer treatment; antioxidants 1. Introduction Phytoestrogens are naturally occurring compounds in plants and are characterized by a close structural similarity to estrogens. This allows them to act as weak estrogenic factors and interfere with hormonal signaling. Several reports suggest that phytoestrogens may have a positive effect on the prevention of menopausal symptoms, type 2 diabetes, cardiovascular disease, obesity, and cancer. These health benefits are presumably linked to their anti-inflammatory, anti-tumoral, anti-allergic, antioxidant, anti-thrombotic, and hepatoprotective properties [1]. The interest in phytoestrogens and cancer began after the observation that the consumption of soy and soy-derived foods was correlated with a decreased incidence of breast [2], ovarian [3], and prostate cancer [4]. In fact, the levels of genistein, the main soy isoflavonoid, and other phytoestrogens in plasma are inversely correlated to the risk of developing several types of cancer [5–8]. Phytoestrogens have been extensively tested in vitro and in vivo as anti-cancer treatments, although they have also been studied as adjuvant treatments to improve the response to chemotherapy, Biology 2020, 9, 427; doi:10.3390/biology9120427 www.mdpi.com/journal/biology Biology 2020, 9, 427 2 of 19 Biology 2020, 9, x 2 of 18 hormonotherapy, and radiotherapy. However, some studies alert that phytoestrogen consumption consumption may interfere with cancer treatments and be harmful to patients. In this review, we may interfere with cancer treatments and be harmful to patients. In this review, we analyze the analyze the current knowledge of the anti-tumoral properties of phytoestrogens and discuss their current knowledge of the anti-tumoral properties of phytoestrogens and discuss their potential use potential use as agents for cancer prevention and treatment. For this, we have searched the Pubmed as agents for cancer prevention and treatment. For this, we have searched the Pubmed (https: (https://pubmed.ncbi.nlm.nih.gov/), Google Scholar (https://scholar.google.es/), and Scopus //pubmed.ncbi.nlm.nih.gov/), Google Scholar (https://scholar.google.es/), and Scopus databases (https: databases (https://www.scopus.com/home.uri) for articles regarding phytoestrogens and cancer from //www.scopus.com/home.uri) for articles regarding phytoestrogens and cancer from the last 25 years the last 25 years (1995–2020). To study the combination of phytoestrogens and anti-cancer treatments, (1995–2020). To study the combination of phytoestrogens and anti-cancer treatments, especially the last especially the last six years (2014–2020) were considered. We also searched clinical trial databases to six years (2014–2020) were considered. We also searched clinical trial databases to include those trials, include those trials, finished or ongoing, using phytoestrogens for cancer patients. finished or ongoing, using phytoestrogens for cancer patients. 2. Phytoestrogen Phytoestrogen Structure Structure and and Classification Classification Even though phytoestrogens areare aa largelarge andand heterogenicheterogenic group, group, all all of of them them are are characterized characterized by by a aphenolic phenolic ring ring and and two two hydroxyl hydroxyl groups groups (Figure (Figure1 ),1), which which are are crucial crucial for for the the binding binding toto thethe estrogenestrogen receptors (ER). The agonist or antagonist properties of phytoestrogens depend on their phenolic group [[1]1].. BasedBased on on their their structure, structure, phytoestrogens phytoestrogens are classifiedare classified into threeinto mainthree classes,main classes, which includewhich includeflavonoids, flavonoids, lignans, lignans, and stilbenes and stilbenes [9,10]. [9,10]. Figure 1. Comparison of the chemical structure of the different classes of phytoestrogens and 17β-estradiol. Figure 1. Comparison of the chemical structure of the different classes of phytoestrogens and 17β- 2.1. Flavonoidsestradiol. 2.1. FlavonoidsFlavonoids present the typical structure C6-C3-C6, with two aromatic rings (benzene A and B) joined together by a chain of 3 carbons cycled through an atom of oxygen (Figure1)[ 11]. Flavonoids are commonlyFlavonoids divided present into several the typical sub-classes, structure based C6- onC3 the-C6, connection with two positionaromatic of rings the B (benzene and C rings, A and as well B) joinedas the degreetogether of by saturation, a chain of oxidation, 3 carbons and cycled hydroxylation through an of atom the C of ring oxygen (Figure (Figure1). This 1) subclassification[11]. Flavonoids areincludes commonly isoflavonoids divided into (isoflavones several sub and-classes, coumestans), based on flavones, the connection flavonols, position flavan-3-ols of the B (or and catechins), C rings, asflavanones, well as the chalcones, degree andof saturation, anthocyanins oxidation, [1,11–14 and]. hydroxylation of the C ring (Figure 1). This subclassificationIsoflavonoids includes are compounds isoflavonoids derived (isoflavones from plant and metabolism, coumestans), and flavones, their structure flavonols, consists flavan of-3 a- ols3-phenylchroman (or catechins), flavanones, skeleton. They chalcones, are also and divided anthocyanins into two major [1,11– groups,14]. isoflavones, and coumestans. IsoflavonesIsoflavonoids are flavonoids are compounds in which derived the B ring from is plant linked metabolism to the heterocyclic, and their ring structure at the C3 consists instead of ofa 3the-phenylchroman C2 position (Figure skeleton.1)[ 15 ].They Genistein are also and daidzeindivided into constitute two upmajor to 90%groups, of isoflavones isoflavones found, and in coumestans.soybeans [16 ],Isoflavones and formononetin are flavonoids and biochanin in which Athe are B mainlyring is linked found to in the red heterocyclic clover. Isoflavones ring at the can C3 be insteadfound in of their the freeC2 position form or in(Figure their esterified 1) [15]. Genistein forms [15 and]. Coumestans, daidzein constitute the other up subclass to 90% of of isoflavonoids, isoflavones foundhave a 1-benzoxolo(3,2-c)chromen-6-onein soybeans [16], and formononetin structure and formed biochanin by a benzoxoleA are mainly fused found with a chromen-2-one.in red clover. Isoflavones can be found in their free form or in their esterified forms [15]. Coumestans, the other subclass of isoflavonoids, have a 1-benzoxolo(3,2-c)chromen-6-one structure formed by a benzoxole Biology 2020, 9, 427 3 of 19 One of the most studied coumestans is coumestrol, considered an endocrine disruptor, as it has the potential to bind to both ERs with similar affinity as estradiol, affecting the estrogenic signaling cascade [17]. Although the estrogenic activity of coumestrol is weaker than that of estradiol, it is 30 to 100 times greater than that of other isoflavones [18], due to the position of its two hydroxy groups, which match estradiol. This chemical structure also gives coumestrol the ability to inhibit aromatase and 3α-hydroxysteroid dehydrogenase [19], which are involved in the synthesis of steroid hormones [20]. Flavones are another type of
Recommended publications
  • Pharmacokinetic Interactions Between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance
    life Review Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance Laura Rombolà 1 , Damiana Scuteri 1,2 , Straface Marilisa 1, Chizuko Watanabe 3, Luigi Antonio Morrone 1, Giacinto Bagetta 1,2,* and Maria Tiziana Corasaniti 4 1 Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, Section of Preclinical and Translational Pharmacology, University of Calabria, 87036 Rende, Italy; [email protected] (L.R.); [email protected] (D.S.); [email protected] (S.M.); [email protected] (L.A.M.) 2 Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy 3 Department of Physiology and Anatomy, Tohoku Pharmaceutical University, 981-8558 Sendai, Japan; [email protected] 4 School of Hospital Pharmacy, University “Magna Graecia” of Catanzaro and Department of Health Sciences, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0984-493462 Received: 28 May 2020; Accepted: 30 June 2020; Published: 4 July 2020 Abstract: The therapeutic efficacy of a drug or its unexpected unwanted side effects may depend on the concurrent use of a medicinal plant. In particular, constituents in the medicinal plant extracts may influence drug bioavailability, metabolism and half-life, leading to drug toxicity or failure to obtain a therapeutic response. This narrative review focuses on clinical studies improving knowledge on the ability of selected herbal medicines to influence the pharmacokinetics of co-administered drugs. Moreover, in vitro studies are useful to anticipate potential herbal medicine-drug interactions.
    [Show full text]
  • Nutraceuticals Brian Lockwood
    CjigVXZji^XVah HZXdcYZY^i^dc 7g^VcAdX`lddY 00 Prelim 2/3/07 18:51 Page i Nutraceuticals 00 Prelim 2/3/07 18:51 Page ii 00 Prelim 2/3/07 18:51 Page iii Nutraceuticals A guide for healthcare professionals Second edition Brian Lockwood BPharm, PhD, MRPharmS Senior Lecturer in Pharmacy, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK London • Chicago 00 Prelim 2/3/07 18:51 Page iv Published by the Pharmaceutical Press An imprint of RPS Publishing 1 Lambeth High Street, London SE1 7JN, UK 100 South Atkinson Road, Suite 200, Grayslake, IL 60030–7820, USA © Pharmaceutical Press 2007 is a trade mark of RPS Publishing RPS Publishing is the publishing organisation of the Royal Pharmaceutical Society of Great Britain First edition published 2002 Second edition published 2007 Typeset by Type Study, Scarborough, North Yorkshire Printed in Great Britain by TJ International, Padstow, Cornwall ISBN 978 0 85369 659 9 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, without the prior written permission of the copyright holder. The publisher makes no representation, express or implied, with regard to the accuracy of the information contained in this book and cannot accept any legal responsibility or liability for any errors or omissions that may be made. The right of Brian Lockwood to be identified as the author of this work has been asserted by him in accordance with sections 77 and 78 and subject to section 79(6) of the Copyright, Designs and Patents Act, 1988.
    [Show full text]
  • Memorandum Date: June 6, 2014
    DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Memorandum Date: June 6, 2014 From: Bisphenol A (BPA) Joint Emerging Science Working Group Smita Baid Abraham, M.D. ∂, M. M. Cecilia Aguila, D.V.M. ⌂, Steven Anderson, Ph.D., M.P.P.€* , Jason Aungst, Ph.D.£*, John Bowyer, Ph.D. ∞, Ronald P Brown, M.S., D.A.B.T.¥, Karim A. Calis, Pharm.D., M.P.H. ∂, Luísa Camacho, Ph.D. ∞, Jamie Carpenter, Ph.D.¥, William H. Chong, M.D. ∂, Chrissy J Cochran, Ph.D.¥, Barry Delclos, Ph.D.∞, Daniel Doerge, Ph.D.∞, Dongyi (Tony) Du, M.D., Ph.D. ¥, Sherry Ferguson, Ph.D.∞, Jeffrey Fisher, Ph.D.∞, Suzanne Fitzpatrick, Ph.D. D.A.B.T. £, Qian Graves, Ph.D.£, Yan Gu, Ph.D.£, Ji Guo, Ph.D.¥, Deborah Hansen, Ph.D. ∞, Laura Hungerford, D.V.M., Ph.D.⌂, Nathan S Ivey, Ph.D. ¥, Abigail C Jacobs, Ph.D.∂, Elizabeth Katz, Ph.D. ¥, Hyon Kwon, Pharm.D. ∂, Ifthekar Mahmood, Ph.D. ∂, Leslie McKinney, Ph.D.∂, Robert Mitkus, Ph.D., D.A.B.T.€, Gregory Noonan, Ph.D. £, Allison O’Neill, M.A. ¥, Penelope Rice, Ph.D., D.A.B.T. £, Mary Shackelford, Ph.D. £, Evi Struble, Ph.D.€, Yelizaveta Torosyan, Ph.D. ¥, Beverly Wolpert, Ph.D.£, Hong Yang, Ph.D.€, Lisa B Yanoff, M.D.∂ *Co-Chair, € Center for Biologics Evaluation & Research, £ Center for Food Safety and Applied Nutrition, ∂ Center for Drug Evaluation and Research, ¥ Center for Devices and Radiological Health, ∞ National Center for Toxicological Research, ⌂ Center for Veterinary Medicine Subject: 2014 Updated Review of Literature and Data on Bisphenol A (CAS RN 80-05-7) To: FDA Chemical and Environmental Science Council (CESC) Office of the Commissioner Attn: Stephen M.
    [Show full text]
  • Coumestrol Suppresses Proliferation of ES2 Human Epithelial Ovarian Cancer Cells
    W LIM, W JEONG and others Coumestrol inhibits progression 228:3 149–160 Research of EOC Coumestrol suppresses proliferation of ES2 human epithelial ovarian cancer cells Whasun Lim1,*, Wooyoung Jeong2,* and Gwonhwa Song1 1Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 136-713, Correspondence Republic of Korea should be addressed 2Department of Animal Resources Science, Dankook University, Cheonan 330-714, to G Song Republic of Korea Email *(W Lim and W Jeong contributed equally to this work) [email protected] Abstract Coumestrol, which is predominantly found in soybean products as a phytoestrogen, Key Words has cancer preventive activities in estrogen-responsive carcinomas. However, effects and " ovary molecular targets of coumestrol have not been reported for epithelial ovarian cancer (EOC). " reproduction In the present study, we demonstrated that coumestrol inhibited viability and invasion and " reproductive tract induced apoptosis of ES2 (clear cell-/serous carcinoma origin) cells. In addition, immuno- " coumestrol reactive PCNA and ERBB2, markers of proliferation of ovarian carcinoma, were attenuated in " clear cell carcinoma their expression in coumestrol-induced death of ES2 cells. Phosphorylation of AKT, p70S6K, ERK1/2, JNK1/2, and p90RSK was inactivated by coumestrol treatment in a dose- and time- dependent manner as determined in western blot analyses. Moreover, PI3K inhibitors Journal of Endocrinology enhanced effects of coumestrol to decrease phosphorylation of AKT, p70S6K, S6, and ERK1/2. Furthermore, coumestrol has strong cancer preventive effects as compared to other conventional chemotherapeutics on proliferation of ES2 cells. In conclusion, coumestrol exerts chemotherapeutic effects via PI3K and ERK1/2 MAPK pathways and is a potentially novel treatment regimen with enhanced chemoprevention activities against progression of EOC.
    [Show full text]
  • 10/12/2019 Herbal Preparations with Phytoestrogens- Overview of The
    Herbal preparations with phytoestrogens- overview of the adverse drug reactions Introduction For women suffering from menopausal symptoms, treatment is available if the symptoms are particularly troublesome. The main treatment for menopausal symptoms is hormone replacement therapy (HRT), although other treatments are also available for some of the symptoms (1). In recent years, the percentage of women taking hormone replacement therapy has dropped (2, 3). Many women with menopausal symptoms choose to use dietary supplements on a plant-based basis, probably because they consider these preparations to be "safe" (4). In addition to product for relief of menopausal symptoms, there are also preparations on the market that claim to firm and grow the breasts by stimulating the glandular tissue in the breasts (5). All these products contain substances with an estrogenic activity, also called phytoestrogens. These substances are found in a variety of plants (4). In addition, also various multivitamin preparations are on the market that, beside the vitamins and minerals, also contain isoflavonoids. Because those are mostly not specified and present in small quantities and no estrogenic effect is to be expected, they are not included in this overview. In 2015 and 2017 the Netherlands Pharmacovigilance Centre Lareb informed the Netherlands Food and Consumer Product Safety Authority (NVWA) about the received reports of Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Products MenoCool® and Menohop® (6, 7). Reports From September 1999 until November 2019 the Netherlands Pharmacovigilance Centre Lareb received 51 reports of the use of phytoestrogen containing preparations (see Appendix 1). The reports concern products with various herbs to which an estrogenic effect is attributed.
    [Show full text]
  • Characterization of the Inhibition of Genistein
    CHARACTERIZATION OF THE INHIBITION OF GENISTEIN GLUCURONIDATION BY BISPHENOL A IN HUMAN AND RAT LIVER MICROSOMES By JANIS LAURA COUGHLIN A thesis submitted to the Graduate School-New Brunswick Rutgers, The State University of New Jersey and The Graduate School of Biomedical Sciences University of Medicine and Dentistry of New Jersey in partial fulfillment of the requirements for the degree of Master of Science Joint Graduate Program in Toxicology written under the direction of Dr. Brian Buckley and approved by __________________________________ __________________________________ __________________________________ __________________________________ New Brunswick, New Jersey OCTOBER 2011 ABSTRACT OF THE THESIS Characterization of the Inhibition of Genistein Glucuronidation by Bisphenol A in Human and Rat Liver Microsomes By JANIS LAURA COUGHLIN Thesis Director: Dr. Brian Buckley Genistein is a natural phytoestrogen that is found abundantly in the soybean. Bisphenol A (BPA) is a synthetic chemical used in the synthesis of polycarbonate plastics and epoxy resins. Endocrine disrupting properties of both genistein and BPA have been well established by various laboratories. Because the adverse biological effects caused by genistein and BPA are similar, and may include common co-exposure scenarios in the general population such as in the consumption of a soy-milk latte from a polycarbonate plastic coffee mug, analysis of the perturbation of the metabolism via glucuronidation of genistein in the presence of BPA has been assessed. Human and rat liver microsomes were exposed to varying doses of genistein (0 to 250 μM) in the absence (0 μM) or presence (25 μM) of BPA. Treatment with 25 μM BPA caused non-competitive inhibition of the glucuronidation of genistein in human liver microsomes with a Ki value of 58.7 μM, represented by a decrease in Vmax from 0.93 ± 0.10 nmol/min/mg in the ii absence of BPA to 0.62 ± 0.05 nmol/min/mg in the presence of BPA, and a negligible change in Km values between treatment groups.
    [Show full text]
  • In Vitro Study of Flavonoids, Fatty Acids, and Steroids on Proliferation of Rat Hepatic Stellate Cells Farid A
    In vitro Study of Flavonoids, Fatty Acids, and Steroids on Proliferation of Rat Hepatic Stellate Cells Farid A. Badriaa,*, Abdel-Aziz A. Dawidarb, Wael E. Houssena, and Wayne T. Shierc a Pharmacognosy Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. E-mail: [email protected] b Chemistry Department, Faculty of Sciences, Mansoura University, Mansoura 35516 Egypt c Medicinal Chemistry Department, College of Pharmacy, University of Minnesota, Minne- apolis MN 55455 USA * Author for correspondence and reprint requests Z. Naturforsch. 60c, 139Ð142 (2005); received November 9/December 8, 2004 There is a wealth of evidence that hepatic stellate cells (HSCs) orchestrate most of the important events in liver fibrogenesis. After liver injury, HSCs become activated to a profi- brogenic myofibroblastic phenotype and can regulate net deposition of collagens and other matrix proteins in the liver. The proliferation of HSCs is mainly stimulated by the platelet- derived growth factor (PDGF). In this study, some compounds from natural resources have been tested for their activity to inhibit PDGF-driven proliferative activity of rat HSCs. Api- genin, quercetin, genistein, daidzin, and biochanin A exhibited > 75% inhibitory activity against HSC-T6. It was found that, γ-linolenic (γ-Ln), eicosapentanoic (EPA) and α- linolenic (α-Ln) acids showed a high inhibitory effect on proliferation of rat HSCs at 50 nmol/l. Cholest-4-ene-3,6-dione and stigmastone-4-en-3,6-dione are the most active steroids with in- hibitory activities > 80% and this is most likely due to the presence of the 4-en-3,6-dione moiety in both compounds.
    [Show full text]
  • Hop Compounds: Extraction Techniques, Chemical Analyses, Antioxidative, Antimicrobial, and Anticarcinogenic Effects
    nutrients Review Hop Compounds: Extraction Techniques, Chemical Analyses, Antioxidative, Antimicrobial, and Anticarcinogenic Effects Maša Knez Hrnˇciˇc 1,†, Eva Španinger 2,†, Iztok Jože Košir 3, Željko Knez 1 and Urban Bren 2,* 1 Laboratory of Separation Processes and Product Design, Faculty of Chemistry and Chemical Engineering, University of Maribor, Smetanova ulica 17, SI-2000 Maribor, Slovenia; [email protected] (M.K.H.); [email protected] (Ž.K.) 2 Laboratory of Physical Chemistry and Chemical Thermodynamics, Faculty of Chemistry and Chemical Engineering, University of Maribor, Smetanova ulica 17, SI-2000 Maribor, Slovenia; [email protected] 3 Slovenian Institute of Hop Research and Brewing, Cesta Žalskega Tabora 2, SI-3310 Žalec, Slovenia; [email protected] * Correspondence: [email protected]; Tel.: +386-2-2294-421 † These authors contributed equally to this work. Received: 7 December 2018; Accepted: 18 January 2019; Published: 24 January 2019 Abstract: Hop plants comprise a variety of natural compounds greatly differing in their structure and properties. A wide range of methods have been developed for their isolation and chemical analysis, as well as for determining their antioxidative, antimicrobial, and antigenotoxic potentials. This contribution provides an overview of extraction and fractionation techniques of the most important hop compounds known for their health-promoting features. Although hops remain the principal ingredient for providing the taste, stability, and antimicrobial protection of beer, they have found applications in the pharmaceutical and other food industries as well. This review focuses on numerous health-promoting effects of hops raging from antioxidative, sedative, and anti-inflammatory potentials, over anticarcinogenic features to estrogenic activity.
    [Show full text]
  • Simultaneous Determination of Isoflavones, Saponins And
    September 2013 Regular Article Chem. Pharm. Bull. 61(9) 941–951 (2013) 941 Simultaneous Determination of Isoflavones, Saponins and Flavones in Flos Puerariae by Ultra Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry Jing Lu,a Yuanyuan Xie,a Yao Tan, a Jialin Qu,a Hisashi Matsuda,b Masayuki Yoshikawa,b and Dan Yuan*,a a School of Traditional Chinese Medicine, Shenyang Pharmaceutical University; 103 Wenhua Rd., Shenyang 110016, P.R. China: and b Department of Pharmacognosy, Kyoto Pharmaceutical University; Shichono-cho, Misasagi, Yamashina-ku, Kyoto 607-8412, Japan. Received April 7, 2013; accepted June 6, 2013; advance publication released online June 12, 2013 An ultra performance liquid chromatography (UPLC) coupled with quadrupole time-of-flight mass spectrometry (QTOF/MS) method is established for the rapid analysis of isoflavones, saponins and flavones in 16 samples originated from the flowers of Pueraria lobata and P. thomsonii. A total of 25 isoflavones, 13 saponins and 3 flavones were identified by co-chromatography of sample extract with authentic standards and comparing the retention time, UV spectra, characteristic molecular ions and fragment ions with those of authentic standards, or tentatively identified by MS/MS determination along with Mass Fragment software. Moreover, the method was validated for the simultaneous quantification of 29 components. The samples from two Pueraria flowers significantly differed in the quality and quantity of isoflavones, saponins and flavones, which allows the possibility of showing their chemical distinctness, and may be useful in their standardiza- tion and quality control. Dataset obtained from UPLC-MS was processed with principal component analysis (PCA) and orthogonal partial least squared discriminant analysis (OPLS-DA) to holistically compare the dif- ference between both Pueraria flowers.
    [Show full text]
  • Endocrine-Immune-Paracrine Interactions in Prostate Cells As Targeted by Phytomedicines
    Published OnlineFirst January 13, 2009; DOI: 10.1158/1940-6207.CAPR-08-0062 Published Online First on January 13, 2009 as 10.1158/1940-6207.CAPR-08-0062 Cancer Prevention Research Endocrine-Immune-Paracrine Interactions in Prostate Cells as Targeted by Phytomedicines Nora E. Gray, Xunxian Liu, Renee Choi, Marc R. Blackman and Julia T. Arnold Abstract Dehydroepiandrosterone (DHEA) is used as a dietary supplement and can be metabolized to androgens and/or estrogens in the prostate. We investigated the hypothesis that DHEA metabolism may be increased in a reactive prostate stroma environment in the presence of proinflammatory cytokinessuchastransforminggrowth factor β1(TGFβ1), and further, whether red clover extract, which contains a variety of compounds including isoflavones, can reverse this effect. LAPC-4 prostate cancer cells were grown in coculture with prostate stromal cells (6S) and treated with DHEA +/− TGFβ1 or interleukin-6. Prostate-specific anti- gen (PSA) expression and testosterone secretion in LAPC-4/6S cocultures were compared with those in monocultured epithelial and stromal cells by real-time PCR and/or ELISA. Combined administration of TGFβ1 + DHEA to cocultures increased PSA protein secretion two to four times, and PSA gene expression up to 50-fold. DHEA + TGFβ1 also increased coculture production of testosterone over DHEA treatment alone. Red clover isoflavone treatment led to a dose-dependent decrease in PSA protein and gene expression and tes- tosterone metabolism induced by TGFβ1 + DHEA in prostate LAPC-4/6S cocultures. In this coculture model of endocrine-immune-paracrine interactionsin the prostate,TGF β1 greatly increased stromal-mediated DHEA effects on testosterone production and epithelial cell PSA production, whereas red clover isoflavones reversed these effects.
    [Show full text]
  • Phytoestrogen Concentrations in Serum and Spot
    698 Cancer Epidemiology, Biomarkers & Prevention Phytoestrogen Concentrations in Serum and Spot Urine as Biomarkers for Dietary Phytoestrogen Intake and Their Relation to Breast Cancer Risk in European Prospective Investigation of Cancer and Nutrition-Norfolk Philip B. Grace,1 James I. Taylor,1 Yen-Ling Low,1 Robert N. Luben,2 Angela A. Mulligan,2 Nigel P. Botting,3 Mitch Dowsett,4 Ailsa A. Welch,2 Kay-Tee Khaw,2 Nick J. Wareham,2 Nick E. Day,2 and Sheila A. Bingham1,2 1MRC Dunn Human Nutrition Unit, Cambridge, United Kingdom; 2European Prospective Investigation of Cancer and Nutrition, Institute of Public Health and Strangeways Research Laboratories, Cambridge, United Kingdom; 3School of Chemistry, University of St. Andrews, Fife, United Kingdom; and 4Royal Marsden Hospital, London, United Kingdom Abstract Subjects of this study consisted of 333 women (aged 45– creatinine) correlated strongly with that in serum, with 75 years) drawn from a large United Kingdom prospec- Pearson correlation coefficients > 0.8. There were sig- tive study of diet and cancer, the European Prospective nificant relationships (P < 0.02) between both urinary Investigation of Cancer and Nutrition-Norfolk study. and serum concentrations of isoflavones across increas- Using newly developed gas chromatography/mass ing tertiles of dietary intakes. Urinary enterodiol and spectrometry and liquid chromatography/mass spectro- enterolactone and serum enterolactone were signifi- metry methods incorporating triply 13C-labeled stand- cantly correlated with dietary fiber intake (r =0.13– ards, seven phytoestrogens (daidzein, genistein, 0.29). Exposure to all isoflavones was associated with glycitein, O-desmethylangolensin, equol, enterodiol, increased breast cancer risk, significantly so for equol and enterolactone) were measured in 114 spot urines and daidzein.
    [Show full text]
  • LGC Standards Pharmacopoeial Reference Standards 2014
    LL CTS INKSP RODUTO A L P ITH W WEBSHO LGC Standards Pharmacopoeial reference standards 2014 FOR STANDARDS WITH CofA SEE OUR CATALOGUE: PHARMACEUTICAL IMPURITIES AND PRIMARY REFERENCE STANDARDS LGC Quality – ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043 Pharmaceutical impurities Code Product CAS No. CS Price Unit Adiphenine Hydrochloride O LGC Standards N O MM1172.00 Adiphenine Hydrochloride 50-42-0 A 250mg HCl Pharmaceutical impurities and Adrenaline Tartrate OH H OH O OH primary reference standardsMM0614.00 2014 N OH Adrenaline Tartrate 51-42-3 A 500mg OH OH O OH OH H MM0614.02 L-Adrenaline 51-43-4 A 500mg OH N OH Imp. C (EP) as Hydrochloride: 1-(3,4-Di- O H OH MM0614.13 hydroxyphenyl)-2-(methylamino)ethanone 62-13-5 A 100mg N HCl Hydrochloride (Adrenalone Hydrochloride) OH (1R)-1-(3,4-Dihydroxyphenyl)-2- OH O S O MM0614.01 methylaminoethanesulphonic Acid H 78995-75-2 A 100mg OH N (Adrenaline -Sulphonate) OH Alanine NH2 MM0566.00 Alanine 56-41-7 A 500mg OH O Imp. A (Pharmeuropa): (2 S)-2-Aminobutanedioic Acid O NH 2 MM0567.00 OH (Aspartic Acid) 56-84-8 A 500mg OH O Albendazole O H MM0382.00 Albendazole N O 54965-21-8 A 500mg N H S N Imp. A (EP): 5-(Propylsulphanyl)-1H- H MM0382.01 N 80983-36-4 A 100mg NH2 benzimidazol-2-amine S N O H Imp. B (EP): Methyl [5-Propylsulphinyl)- N O MM0382.02 N 54029-12-8 A 100mg H 1H-benzimidazol-2-yl]carbamate S N O O H Imp.
    [Show full text]